+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Caris Life Sciences Inc - Product Pipeline Analysis, 2020 Update

  • ID: 5240164
  • Company Profile
  • January 2021
  • 30 pages
  • GlobalData

FEATURED COMPANIES

  • MP Biomedicals LLC
  • Prometheus Research LLC
  • RefleXion Medical Inc
  • Zymo Research Corp
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a platform that identifies the novel molecular targets to inform and enhance drug development and advanced diagnostics. Caris Life provides healthcare information and comprehensive tumor profiling service through its Caris molecular intelligence; DEAN, a proprietary artificial intelligence analytics engine to analyze the whole exome, whole transcriptome and complete cancer proteome. The company’s products are used in therapeutic development, drug delivery, diagnostics and disease monitoring applications. The company offers its molecular solutions for patients, physicians, payers and biopharmaceutical organizations. The company has operations in Phoenix, the US and Basel, Switzerland. Caris Life is headquartered in Irving, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Caris Life Sciences Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • MP Biomedicals LLC
  • Prometheus Research LLC
  • RefleXion Medical Inc
  • Zymo Research Corp
Caris Life Sciences Inc Company Overview
  • Caris Life Sciences Inc Company Snapshot
  • Caris Life Sciences Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Caris Life Sciences Inc - Pipeline Analysis Overview
  • Caris Life Sciences Inc - Key Facts
  • Caris Life Sciences Inc - Major Products and Services
  • Caris Life Sciences Inc Pipeline Products by Development Stage
Caris Life Sciences Inc Pipeline Products Overview
  • Companion Diagnostic Assay - Breast Cancer
  • Companion Diagnostic Assay - Breast Cancer Product Overview
  • Companion Diagnostic Assay - Pancreatic Cancer
  • Companion Diagnostic Assay - Pancreatic Cancer Product Overview
  • Companion Diagnostic Test - Rare FGFR Fusions
  • Companion Diagnostic Test - Rare FGFR Fusions Product Overview
  • Diagnostic Test - PSA
  • Diagnostic Test - PSA Product Overview
  • MI Exome
  • MI Exome Product Overview
  • MI Transcriptome
  • MI Transcriptome Product Overview
Caris Life Sciences Inc - Key Competitors

Caris Life Sciences Inc - Key Employees

Caris Life Sciences Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Caris Life Sciences Inc, Recent Developments
  • Sep 22, 2020: Caris Precision Oncology Alliance welcomes UT Southwestern Medical Center
  • Aug 25, 2020: Penn State Cancer Institute joins Caris Life Sciences' Precision Oncology Alliance
  • Jul 21, 2020: Caris Precision Oncology Alliance welcomes Montefiore Health System
  • Feb 11, 2020: Caris Life Sciences appoints new Executive Medical Director
  • Dec 11, 2019: Caris Life Sciences launches first ever molecular AI product: A clinical genomic profiling similarity score
  • Dec 10, 2019: Caris Life Sciences to present data evaluating PI3K pathway alterations at the 2019 San Antonio Breast Cancer Symposium (SABCS)
  • Dec 04, 2019: Caris Life Sciences and Ambry Genetics partner to advance cancer care
  • Oct 15, 2019: Caris Life Sciences further bolsters scientific advisory board with four new members
  • Aug 20, 2019: Caris Life Sciences accelerates growth through development of pioneering state-of-the-art corporate park
  • Jul 23, 2019: University of Puerto Rico Joins Caris Life Sciences’ Precision Oncology Alliance
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Caris Life Sciences Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Caris Life Sciences Inc Pipeline Products by Equipment Type
  • Caris Life Sciences Inc Pipeline Products by Indication
  • Caris Life Sciences Inc, Key Facts
  • Caris Life Sciences Inc, Major Products and Services
  • Caris Life Sciences Inc Number of Pipeline Products by Development Stage
  • Caris Life Sciences Inc Pipeline Products Summary by Development Stage
  • Companion Diagnostic Assay - Breast Cancer - Product Status
  • Companion Diagnostic Assay - Breast Cancer - Product Description
  • Companion Diagnostic Assay - Pancreatic Cancer - Product Status
  • Companion Diagnostic Assay - Pancreatic Cancer - Product Description
  • Companion Diagnostic Test - Rare FGFR Fusions - Product Status
  • Companion Diagnostic Test - Rare FGFR Fusions - Product Description
  • Diagnostic Test - PSA - Product Status
  • Diagnostic Test - PSA - Product Description
  • MI Exome - Product Status
  • MI Exome - Product Description
  • MI Transcriptome - Product Status
  • MI Transcriptome - Product Description
  • Caris Life Sciences Inc, Key Employees
  • Caris Life Sciences Inc, Other Locations
  • Glossary
List of Figures
  • Caris Life Sciences Inc Pipeline Products by Equipment Type
  • Caris Life Sciences Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Zymo Research Corp
  • RefleXion Medical Inc
  • Prometheus Research LLC
  • MP Biomedicals LLC
Note: Product cover images may vary from those shown
Adroll
adroll